Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1961 1
1966 1
1967 2
1971 2
1972 4
1973 2
1974 8
1975 6
1976 5
1977 8
1978 4
1979 5
1980 8
1981 3
1982 9
1983 9
1984 9
1985 9
1986 9
1987 8
1988 11
1989 22
1990 28
1991 14
1992 18
1993 17
1994 11
1995 16
1996 13
1997 23
1998 22
1999 28
2000 29
2001 21
2002 18
2003 11
2004 19
2005 11
2006 13
2007 8
2008 6
2009 9
2010 10
2011 10
2012 7
2013 5
2014 8
2015 11
2016 12
2017 13
2018 9
2019 2
2020 4
2021 3
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

576 results

Results by year

Filters applied: . Clear all
Page 1
Lanosterol reverses protein aggregation in cataracts.
Zhao L, Chen XJ, Zhu J, Xi YB, Yang X, Hu LD, Ouyang H, Patel SH, Jin X, Lin D, Wu F, Flagg K, Cai H, Li G, Cao G, Lin Y, Chen D, Wen C, Chung C, Wang Y, Qiu A, Yeh E, Wang W, Hu X, Grob S, Abagyan R, Su Z, Tjondro HC, Zhao XJ, Luo H, Hou R, Jefferson J, Perry P, Gao W, Kozak I, Granet D, Li Y, Sun X, Wang J, Zhang L, Liu Y, Yan YB, Zhang K. Zhao L, et al. Among authors: perry p. Nature. 2015 Jul 30;523(7562):607-11. doi: 10.1038/nature14650. Epub 2015 Jul 22. Nature. 2015. PMID: 26200341
Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial.
Krystal JH, Kane JM, Correll CU, Walling DP, Leoni M, Duvvuri S, Patel S, Chang I, Iredale P, Frohlich L, Versavel S, Perry P, Sanchez R, Renger J. Krystal JH, et al. Among authors: perry p. Lancet. 2022 Dec 17;400(10369):2210-2220. doi: 10.1016/S0140-6736(22)01990-0. Lancet. 2022. PMID: 36528376 Clinical Trial.
Major lipids, apolipoproteins, and risk of vascular disease.
Emerging Risk Factors Collaboration; Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, Collins R, Thompson SG, Danesh J. Emerging Risk Factors Collaboration, et al. Among authors: perry p. JAMA. 2009 Nov 11;302(18):1993-2000. doi: 10.1001/jama.2009.1619. JAMA. 2009. PMID: 19903920 Free PMC article.
Ethanol Forensic Toxicology.
Perry PJ, Doroudgar S, Van Dyke P. Perry PJ, et al. J Am Acad Psychiatry Law. 2017 Dec;45(4):429-438. J Am Acad Psychiatry Law. 2017. PMID: 29282233
Is lithium a neuroprotective agent?
Vo TM, Perry P, Ellerby M, Bohnert K. Vo TM, et al. Among authors: perry p. Ann Clin Psychiatry. 2015 Feb;27(1):49-54. Ann Clin Psychiatry. 2015. PMID: 25696782 Review.
Drug testing in the workplace.
Phan HM, Yoshizuka K, Murry DJ, Perry PJ. Phan HM, et al. Among authors: perry pj. Pharmacotherapy. 2012 Jul;32(7):649-56. doi: 10.1002/j.1875-9114.2011.01089.x. Epub 2012 May 17. Pharmacotherapy. 2012. PMID: 22605533 Review.
576 results